Promyelocytic Blast Crisis of Chronic Myeloid Leukemia in a Patient Undergoing Therapy with a Tyrosine Kinase Inhibitor

A 58-year-old male with the chronic phase of chronic myeloid leukemia (CML), treated with a tyrosine kinase inhibitor (TKI), bosutinib, since the past two years, presented with bright red bleeding per rectum and disseminated intravascular coagulation. A bone marrow biopsy reverse transcription-polym...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsi, Meghana, Budak-Alpdogan, Tulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141802/
https://www.ncbi.nlm.nih.gov/pubmed/32274275
http://dx.doi.org/10.7759/cureus.7217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141802/
https://www.ncbi.nlm.nih.gov/pubmed/32274275
http://dx.doi.org/10.7759/cureus.7217

Ejemplares similares